S. Shigeta et al., Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitro, ANTIVIR CHE, 10(4), 1999, pp. 195-209
Twenty 2-thiopyrimidine nucleoside analogues were synthesized and examined
for inhibitory activity against herpes simplex virus (HSV) type 1 and 2, va
ricella-zoster virus (VZV), human cytomegalovirus (HCMV) and thymidine kina
se-deficient HSV (HSV-TK-) replication in vitro. 2-thiouracil (thymine) ara
binoside, 2'-deoxy-2-thiouridine (or 2-thiothymidine) and their 5-halogenat
ed derivatives showed anti-HSV activity in both RPMI8226 (human B-lymphobla
stoid cells) and MRC-5 (human embryo lung cells). 2'-deoxy-5-halogenated-2-
thiocytidines were also inhibitory against HSV, whereas 2-thiocytosine arab
inoside and its derivatives were not inhibitory against HSV replication, ex
cept 5-bromo and 5-iodo congeners (TN-31. TN-32). Substitution of the halog
en atom at the 5-position of the pyrimidine rings to an atom with a higher
molecular weight increased anti-HSV and VZV activities, except for the anti
-HSV activity of 2-thiouracil arabinosides. 2'-deoxy-5-methyl-, and 2'-deox
y-5-iodo-2-thiouridines (TN-17. TN-44) showed the most potent anti-HSV acti
vity, and 2'-deoxy-5-chloro- and 2'-deoxy-5-bromo-2-thiocytidines were pote
nt inhibitors of VZV replication. However, none of the compounds inhibited
HCMV and HSV-TK- replication. TN-31 and TN-32 were shown to inhibited HCMV
and HSV-TK- as well as HSV and VZV replication. The cytotoxicity of the 2-t
hio-pyrimidine nucleoside analogues was less than that of the 2-oxy-congene
rs of the compounds (5-iodo-2'-deoxyuridine, 5-iodo-2'-deoxycytidine, thymi
ne arabinoside and cytosine arabinoside). The selectivity index of 2'-deoxy
-5-iodo-thiouridine (TN-44) was higher than that of 5-iodo-deoxyuridine TN-
17 and TN-44 were not cytotoxic to resting or stimulated human peripheral b
lood mononuclear cells at 400 mu M, although TN-32 was cytotoxic at a conce
ntration of 20 mu M.